A Comprehensive Overview of Vision Screening Programmes across 46 Countries.
amblyopia
effectiveness
photoscreening
reduced vision
vision screening
Journal
The British and Irish orthoptic journal
ISSN: 1743-9868
Titre abrégé: Br Ir Orthopt J
Pays: England
ID NLM: 101233819
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
11
2021
accepted:
10
05
2022
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
9
7
2022
Statut:
epublish
Résumé
To describe and compare vision screening programmes and identify variance in number and type of tests used, timing of screening, personnel involved, monitoring and funding to be used as data for optimising, disinvesting or implementing future screening programmes. A questionnaire consisting of nine domains: demography & epidemiology, administration & general background, existing screening, coverage & attendance, tests, follow-up & diagnosis, treatment, cost & benefit and adverse effects was completed by Country Representatives (CRs) recruited from 47 countries. The questionnaire was sufficiently completed for 46 Countries: 42 European countries, China, India, Malawi and Rwanda. Variation of provision was found in; age of screening (0-17 years), tests included (23), types of visual acuity (VA) test used (35 different optotypes), personnel (13), number of screens per child (median 5, range 1-32), and times VA tested (median 3, range 1-30). Infant screening is offered in all countries, whereas childhood vision screening is offered at least once in all countries, but not all regions of each country. All 46 countries provide vision screening between the ages of 3-7 years. Data on screening outcomes for quality assurance was not available from most countries; complete evaluation data was available in 2% of countries, partial data from 43%. Vision screening is highly variable. Some form of VA testing is being undertaken during childhood. Data collection and sharing should be improved to facilitate comparison and to be able to optimise vision screening programmes between regions and countries.
Identifiants
pubmed: 35801077
doi: 10.22599/bioj.260
pmc: PMC9187246
doi:
Types de publication
Journal Article
Langues
eng
Pagination
27-47Informations de copyright
Copyright: © 2022 The Author(s).
Déclaration de conflit d'intérêts
At the time of submission, Dr Carlton was the Editor of British and Irish Orthoptic Journal. She had no role in the peer-review process of this article.
Références
J Med Screen. 2015 Jun;22(2):55-64
pubmed: 25742803
Bull World Health Organ. 2008 Apr;86(4):317-9
pubmed: 18438522
Ear Hear. 2021 Jul-Aug 01;42(4):909-916
pubmed: 33306547
Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):6-8
pubmed: 16451251
Am J Optom Physiol Opt. 1976 Nov;53(11):740-5
pubmed: 998716
Lancet. 2015 Jun 6;385(9984):2308-19
pubmed: 25499167
Acta Ophthalmol. 2015 Dec;93(8):706-12
pubmed: 26149829
Optom Vis Sci. 2012 Nov;89(11):e44-9
pubmed: 23069721
World Health Forum. 1995;16(2):173-8
pubmed: 7794456
Acta Ophthalmol. 2019 May;97(3):e419-e425
pubmed: 30345728
Acta Ophthalmol. 2022 Feb;100(1):e100-e114
pubmed: 33817982
Strabismus. 2021 Sep;29(3):174-181
pubmed: 34224304
Hosp Top. 2020 Apr-Jun;98(2):51-58
pubmed: 32293227
Int J Health Serv. 2009;39(2):271-85
pubmed: 19492625
BMJ Open. 2019 Aug 18;9(8):e030506
pubmed: 31427341
Eye (Lond). 2021 Mar;35(3):739-752
pubmed: 33257800